本页面由Tiger Trade Technology Pte. Ltd.提供服务

Sutro Biopharma Inc

20.68
-0.4400-2.08%
盘后20.680.00000.00%16:42 EDT
成交量:59.82万
成交额:1,238.96万
市值:3.39亿
市盈率:-0.80
高:21.63
开:20.76
低:20.18
收:21.12
52周最高:26.54
52周最低:5.23
股本:1,638.78万
流通股本:1,388.51万
量比:4.00
换手率:4.31%
股息:- -
股息率:- -
每股收益(TTM):-25.8759
每股收益(LYR):-29.6061
净资产收益率:-1810.01%
总资产收益率:-25.80%
市净率:-3.88
市盈率(LYR):-0.70

数据加载中...

2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/02

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]